Fecal Transplant vs. Oral Vancomycin Taper for Recurrent Clostridium difficile Infection.

Title

Fecal Transplant vs. Oral Vancomycin Taper for Recurrent Clostridium difficile Infection.

Creator

Watkins Richard R

Publisher

Infectious Disease Alert

Date

2017
2017-01

Description

In a small randomized, controlled trial that compared fecal microbiota transplant (FMT) administered by enema to a six-week oral vancomycin taper, FMT was not more effective for patients with recurrent Clostridium difficile infection.

Subject

Recurrence; Costs and Cost Analysis; Enema; Administration; Oral; Treatment Outcomes; Randomized Controlled Trials; Cost Benefit Analysis; Microbiota; Transplant Donors; Vancomycin – Therapeutic Use; Clostridium Infections – Drug Therapy; Clostridium Infections – Prevention and Control; Clostridium Infections – Therapy; Feces – Transplantation; Recurrence – Therapy; Vancomycin – Administration and Dosage; Vancomycin – Economics

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

1–2

Issue

4

Volume

36

Citation

Watkins Richard R, “Fecal Transplant vs. Oral Vancomycin Taper for Recurrent Clostridium difficile Infection.,” NEOMED Bibliography Database, accessed January 21, 2021, https://neomed.omeka.net/items/show/5830.

Social Bookmarking